FDA Inspection 1218664 — BioLife Plasma Services LP
The FDA completed an inspection of BioLife Plasma Services LP on September 12, 2023 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 12, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbus, OH (United States)